Furthermore, GEPIA and ULCAN databases revealed a close association between high expression of SERPINE2 and clinical progression in COAD patients, indicating a correlation between increased levels of SERPINE2 and malignant progression as well as lymph node metastasis(Figure 2C). This evidence concerns the gene SERPINE2 and metastatic malignant neoplasm in the lymph nodes.